Adamis Pharmaceuticals Corporation is a publicly traded OTC: ADMP biopharmaceutical company combining specialty pharmaceuticals and biotechnology products to create a variety of treatment options in the areas of oncology cancer , immunology, infectious diseases viruses , as well as allergic and respiratory conditions. Adamis is built on a business model that entails licensing innovative programs from companies or institutions and then advancing these initiatives through clinical development, regulatory approvals, and marketing. In order to efficiently accomplish its objectives, the Company operates through two subsidiaries Adamis Laboratories specialty pharmaceuticals and Adamis Therapeutics biotechnology . This structure permits each division to complement one other by providing a combination of pharmaceutical revenue and biotechnology blockbuster potential. The specialty pharmaceutical division will provide revenue to support the development of the Company s therapeutic products.
Quote | Adamis Pharmaceuticals Corporation (NASDAQ:ADMP)
Last: | $2.07 |
---|---|
Change Percent: | -4.0% |
Open: | $2.6 |
Close: | $2.07 |
High: | $2.6 |
Low: | $1.91 |
Volume: | 914,730 |
Last Trade Date Time: | 05/26/2023 03:00:00 am |
News | Adamis Pharmaceuticals Corporation (NASDAQ:ADMP)
2023-05-26 13:21:20 ET Gainers: Elevation Oncology ( ELEV ) +70% . Alarum Technologies ( ALAR ) +61% . Bright Health Group ( BHG ) +56% . Onfolio Holdings ( ONFO ) +35% . D-Wave Quantum ( QBTS ) +31% . Marvell Technology ( ...
DMK CEO, Ebrahim (Eboo) Versi, MD, PhD, named CEO and Chairman of the combined company Combined company will have commercial products and a library of development candidates, including two clinical stage programs DPI-125, the lead development program, is a clinical stage therapeutic under...
Message Board Posts | Adamis Pharmaceuticals Corporation (NASDAQ:ADMP)
Subject | By | Source | When |
---|---|---|---|
FDA approves over-the-counter sales of lifesaving opioid overdose | ShortsRClowns | investorshub | 03/29/2023 1:50:31 PM |
whytestocks: $ADMP News Article - SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ROCC, SUM | whytestocks | investorshangout | 03/02/2023 1:55:46 PM |
Yeah saw that now | harry crumb | investorshub | 02/28/2023 1:38:39 PM |
Just an RS | MD3 | investorshub | 02/28/2023 1:26:09 PM |
Hhhmmmm interesting news out, mayb worth a look | harry crumb | investorshub | 02/28/2023 12:42:45 PM |
Adamis Pharmaceuticals Corporation Company Name:
ADMP Stock Symbol:
NASDAQ Market:
Adamis Pharmaceuticals Corporation Website:
News, Short Squeeze, Breakout and More Instantly...